Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis

…, P Castiglia, S De Lorenzo… - European …, 2012 - Eur Respiratory Soc
Linezolid is used off-label to treat multidrug-resistant tuberculosis (MDR-TB) in absence of
systematic evidence. We performed a systematic review and meta-analysis on efficacy, safety …

Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB

S De Lorenzo, JW Alffenaar, G Sotgiu… - European …, 2013 - Eur Respiratory Soc
Clinical experience on meropenem–clavulanate to treat tuberculosis (TB) is anecdotal (according
to case reports on 10 patients). The aim of our case–control study was to evaluate the …

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR-and XDR-TB

…, JA Caminero, R Centis, S De Lorenzo… - European …, 2016 - Eur Respiratory Soc
No large study has ever evaluated the efficacy, safety and tolerability of meropenem/clavulanate
to treat multidrug- and extensively drug-resistant tuberculosis (MDR- and XDR-TB). The …

Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR-and XDR-TB

…, M Tadolini, VA Guizado, S De Lorenzo… - European …, 2016 - Eur Respiratory Soc
No large study to date has ever evaluated the effectiveness, safety and tolerability of
imipenem/clavulanate versus meropenem/clavulanate to treat multidrug- and extensively drug-…

Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience

S Tiberi, L D'Ambrosio, S De Lorenzo… - European …, 2016 - Eur Respiratory Soc
Treatment of multidrug-resistant (MDR) tuberculosis (TB) (defined as resistance to at least
isoniazid and rifampicin, two core first-line drugs for TB treatment) and extensively drug-…

TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?

…, G Bothamley, DM Cirillo, S De Lorenzo… - European …, 2012 - Eur Respiratory Soc
In spite of the growing awareness of emerging drug-resistant Mycobacterium tuberculosis,
the extent of inappropriate tuberculosis (TB) case management may be underestimated, even …

TB and M/XDR-TB infection control in European TB reference centres: the Achilles' heel?

…, G Bothamley, DM Cirillo, S De Lorenzo… - European …, 2011 - Eur Respiratory Soc
The emergence of multidrug-resistant (MDR) tuberculosis (TB), defined as in vitro resistance
to isoniazid and rifampicin, and extensively drug-resistant (XDR)-TB, defined as in vitro …

Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study

…, S Tiberi, G Sotgiu, S De Lorenzo… - European …, 2015 - Eur Respiratory Soc
Linezolid is used off-label to treat multidrug-resistant (MDR) and extensively drug-resistant (XDR)
tuberculosis (TB) [1, 2]. Recently, two systematic reviews and meta-analyses pointed …

Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use

S Tiberi, S De Lorenzo, R Centis… - European …, 2014 - Eur Respiratory Soc
6 Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and second-line
injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J 2013; 42: 156–168. 7 …

Effectiveness and safety of imipenem-clavulanate added to an optimized background regimen (OBR) versus OBR control regimens in the treatment of multidrug …

…, V Alarcon Guizado, S De Lorenzo… - Clinical Infectious …, 2016 - academic.oup.com
TO THE EDITOR—In 2012, among 17 deaths in persons with a clinical diagnosis of Plasmodium
vivax infection analyzed post mortem at a reference center in the Brazilian Amazon, we …